Ngan, Vanessa (December 21, 2009). "Escharotic agents". DermNet NZ. New Zealand Dermatological Society. Archived from the original on April 12, 2013. Retrieved January 1, 2010.
doi.org
Jellinek N, Maloney ME (September 2005). "Escharotic and other botanical agents for the treatment of skin cancer: a review". J. Am. Acad. Dermatol. 53 (3): 487–95. doi:10.1016/j.jaad.2005.04.090. PMID16112359.
McDaniel S, Goldman GD (December 2002). "Consequences of using escharotic agents as primary treatment for nonmelanoma skin cancer". Arch Dermatol. 138 (12): 1593–6. doi:10.1001/archderm.138.12.1593. PMID12472348.
Jellinek N, Maloney ME (September 2005). "Escharotic and other botanical agents for the treatment of skin cancer: a review". J. Am. Acad. Dermatol. 53 (3): 487–95. doi:10.1016/j.jaad.2005.04.090. PMID16112359.
McDaniel S, Goldman GD (December 2002). "Consequences of using escharotic agents as primary treatment for nonmelanoma skin cancer". Arch Dermatol. 138 (12): 1593–6. doi:10.1001/archderm.138.12.1593. PMID12472348.
Ngan, Vanessa (December 21, 2009). "Escharotic agents". DermNet NZ. New Zealand Dermatological Society. Archived from the original on April 12, 2013. Retrieved January 1, 2010.